Notable Analyst Rating Changes 9/5: UL, MON, NAV, HOS Upgraded; ANF, TJX, AMD, NBR Downgraded
More News related to AMD
- David Moenning’s Daily State of the Markets: 7/2
- NVIDIA (NVDA) Falls On Share Loss Rumors
- AMD Continues to Drive Industry Adoption of GPU Acceleration in Enterprise and HPC Environments
- GLOBALFOUNDRIES Announces New Fab 2 Executive Leadership Team
- The 'Best-of-the-Best' Supercomputers Leverage AMD Opteron(TM) Processors
More News related to ANF
- Hollister Opens the Coolest Pier on the Planet
- Edinburgh Partners Limited Discloses 5.04% Stake in Abercrombie & Fitch (ANF)
- Susquehanna Reaffirms a 'Positive' Rating on Abercrombie & Fitch (ANF), Raises Price Target
- SunTrust upgrades Abercrombie & Fitch (ANF) to Buy
- Abercrombie & Fitch (ANF) Announces Closure of its RUEHL Brand; Amends Existing Credit Agreement
More News related to BSX
- Boston Scientific (BSX) volatility of 48 near nine-month lows
- Gabelli Upgrades Boston Scientific (BSX) to Buy
- David Moenning’s Daily State of the Markets: 6/26
- Boston Scientific (BSX) Announces Retirement of Jim Tobin and Appoints Ray Elliott as New President and CEO
- Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
UPGRADES:
UBS upgrades Unilever (NYSE: UL) from Sell to Neutral.
Credit Suisse upgrades Monsanto (NYSE: MON) from Neutral to Outperform.
J.P. Morgan upgrades Navistar (NYSE: NAV) from Neutral to Overweight.
Goldman Sachs upgrades Hornbeck Offshore (NYSE: HOS) from Sell to Neutral with a $50 price target.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades Abercrombie & Fitch Co (NYSE: ANF) from Buy to Sell. Price target slashed from $73 to $45.
Lehman Bros. downgrades TJX Companies (NYSE: TJX) from Overweight to Equalweight.
Merrill Lynch downgrades Advanced Micro Devices (NYSE: AMD) from Neutral to Sell, citing valuation.
Goldman Sachs downgrades Nabors (NYSE: NBR) from Buy to Neutral and lowered its price target from $56 to $41.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Merrill Lynch resumes coverage on Genzyme (Nasdaq: GENZ) with a Buy.
Morgan Stanley assumes coverage on Johnson & Johnson (NYSE: JNJ) with an Overweight.
Morgan Stanley assumes coverage on Boston Scientific (NYSE: BSX) with an Overweight.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+24.77
-0.67Related Entities
- Credit Suisse
- UBS
- JPMorgan
- Goldman Sachs
- Citi
- Morgan Stanley
- Merrill Lynch
- Lehman Brothers
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
